MOUNTAIN VIEW, Calif., Oct. 8 /PRNewswire/ — Concentric
Medical, Inc. today announced the full European launch of
Trevo™, the first device utilizing Stentriever™
technology for clot retrieval in ischemic stroke
patients.
Trevo is the newest offering in a portfolio of products from
Concentric Medical, the company that first introduced retrievers
for acute ischemic stroke. The Trevo’s stent-like design leverages
the company’s long history of developing clot retrieval
technologies for stroke. Backed by years of research, Trevo is the
first and only retriever of its type designed for quick access,
rapid clot integration and predictable clot retrieval in ischemic
stroke patients.
Prior to launch, the Trevo was evaluated in a limited number of
centers across Europe. Professor Olav Jansen, Head of
Interventional Neuroradiology at Universitatsklinikum
Schleswig-Holstein in Kiel, Germany commented from the neuroRAD
congress in Cologne, “I have performed some fast and successful
cases with the new Trevo. This is a powerful and easy-to-use
revascularization device. I now have a safe weapon for treating
stroke.”
Maria Sainz, President and CEO of Concentric Medical, also
commented, “The introduction of the Trevo System in Europe is all
about offering physicians a faster, more confident means of
removing a clot in acute stroke cases. We have always believed that
retrieving the clot has the potential to offer patients a better
outcome. The data in our previous clot retrieval trials, MERCI and
Multi MERCI, have provided sound evidence of the benefits of
retrieving clot for stroke patients. The Trevo is offered as a
complete system for use with Concentric’s microcatheter, balloon
guide catheter and DAC™ catheter making the stroke retrieval
procedure easier and more predictable.”
About Concentric MedicalConcentric Medical is located in
Mountain View, California and is the global leader in the
development of endovascular devic
‘/>”/>
